STOCK TITAN

DUKE Robotics 2026 nine-month loss widens to $2.46M

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
10-Q

Rhea-AI Filing Summary

DUKE Robotics Corp. (DUKR) reported nine-month revenue of $448,000, versus $359,000 in 2025, while net loss widened to $2.46 million from $778,000. Gross profit fell to $182,000 from $203,000; general and administrative expense rose to $2.323 million from $875,000. Third-quarter revenue was $299,000 versus $216,000, and net loss was $813,000 versus $230,000.

At September 30, 2026, cash and cash equivalents were $6.409 million; operating activities used $1.788 million in the nine months. The May 18, 2026, public offering produced approximately $9.225 million in gross proceeds and $7.263 million in net proceeds. Management said existing cash was expected to meet obligations for more than 12 months from approval of the statements.

Operational constraints may push part of the expanded Israel Electric Corporation order into the 2027 cleaning season, though the company expects full completion. Under a November 4, 2026, agreement, DUKE and CRONOS will pursue Greek IC Drone opportunities on an exclusive basis; the company cautioned that identified opportunities may not become binding contracts or generate revenue. Regional hostilities have caused temporary operating disruptions and may affect activities.

1 point · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

1 major · 3 points

How the balance works

Positive

  • Moderate pointNine-month revenue was $448,000, compared with $359,000 in 2025.

Negative

  • Major pointNine-month net loss widened to $2.46 million from $778,000.
  • Moderate pointOperating cash use increased to $1.788 million from $741,000.
  • Minor pointNine-month gross profit declined to $182,000 from $203,000.

Filing Explained

The share-count increase is already reflected; offering warrants and October options are separate, conditional capacity for further share issuance.

This unaudited Form 10-Q reports DUKE had 3,425,978 common shares issued and outstanding on September 30, 2026, versus 2,177,045 on December 31, 2025; the filing gives the same total as of November 16, 2026. The completed increase means existing holders own a smaller percentage absent offsetting changes; warrants and options disclosed in the filing could add shares if exercised.

The May 18, 2026, offering closed with 1,125,000 units, each combining one common share and a five-year warrant to buy one share at $8.60; the over-allotment exercise added warrants to buy 168,750 shares. DUKE also issued 22,595 make-whole shares, and on October 5, 2026, granted 144,600 options at $5.45 that vest over three years; those options are grants, not shares already included in the outstanding count.

A separate amendment dated November 15, 2026, reduces Yossef Balucka’s services for the period from November 1, 2026, through April 30, 2027, for a monthly fee of NIS 20,000 plus applicable VAT; further services require mutual written agreement, or the agreement terminates on April 30.

Nine-month revenue $448,000 Nine months ended September 30, 2026; $359,000 in 2025
Nine-month net loss $2.46 million Nine months ended September 30, 2026; $778,000 in 2025
Third-quarter revenue $299,000 Three months ended September 30, 2026; $216,000 in 2025
Third-quarter net loss $813,000 Three months ended September 30, 2026; $230,000 in 2025
Nine-month gross profit $182,000 Nine months ended September 30, 2026; $203,000 in 2025
Cash and cash equivalents $6.409 million As of September 30, 2026
Net cash used in operating activities $1.788 million Nine months ended September 30, 2026; $741,000 in 2025
Net proceeds from public offering $7.263 million Offering closed May 18, 2026; approximately $9.225 million gross proceeds
cashless exercise provisions technical
"subject to certain adjustments and cashless exercise provisions"
make-whole provision financial
"issued 22,595 additional shares in settlement of the make-whole provision"
A make-whole provision is a clause in a loan or bond that requires a borrower to pay extra cash to lenders if the borrower repays the debt early, compensating them for the interest they would have received. It matters to investors because it protects expected income and affects the value and yield of a bond, and it matters to issuers because it raises the cost of refinancing. Think of it like paying a landlord a lump sum to cover the remaining rent when breaking a lease early.
mark-to-market loss financial
"resulting in a mark-to-market loss"
A mark-to-market loss is the drop in value a company records when it adjusts an asset’s book value to the current market price, like re-pricing items on a shelf to today’s sale value. It matters to investors because these losses change reported profits and balance-sheet strength immediately—affecting earnings, regulatory capital and investor confidence—even if the asset hasn’t been sold and no cash loss has been realized.
beneficial ownership blocker financial
"include a beneficial ownership blocker that limits the exercise"
A beneficial ownership blocker is a legal or structural device that prevents a shareholder from being treated as the ultimate owner of enough shares to trigger control, reporting, or voting thresholds. Think of it like a speed bump that stops an investor from reaching a stake size that would force corporate disclosure or change control rights. Investors care because it affects who controls the company, how shares vote, regulatory filings, takeover risk and therefore potential value or liquidity of their holdings.
short-term lease recognition exemption technical
"account for the arrangement under the short-term lease recognition exemption"
fair value hierarchy financial
"disclosed by the Level within the fair value hierarchy"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What were DUKR's revenue and net loss for the first nine months of 2026?

Revenue was $448,000, compared with $359,000 for the first nine months of 2025. Net loss was $2.46 million, compared with $778,000.

How much cash did DUKR have at September 30, 2026, and how long did management expect it to last?

Cash and cash equivalents were $6.409 million as of September 30, 2026; operating activities used $1.788 million in the nine months ended that date. Management said existing cash was expected to meet obligations for more than 12 months from approval of the statements.

What are the terms of DUKR's collaboration with CRONOS in Greece?

The agreement has an initial term of three years and provides for the parties to share profits from jointly undertaken projects, with DUKE receiving the majority share. The parties will pursue commercial opportunities in Greece, but the company said identified opportunities may not result in binding customer contracts or revenue.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
0001638911 false --12-31 Q3 0001638911 2026-07-01 2026-09-30 0001638911 us-gaap:SubsequentEventMember 2026-10-05 2026-10-05 0001638911 us-gaap:SubsequentEventMember dukr:ViceChairmanMember 2026-10-05 2026-10-05 0001638911 us-gaap:SubsequentEventMember dukr:ChiefTechnologyOfficerMember 2026-10-05 2026-10-05 0001638911 us-gaap:SubsequentEventMember srt:ChiefFinancialOfficerMember 2026-10-05 2026-10-05 0001638911 us-gaap:SubsequentEventMember srt:ChiefExecutiveOfficerMember 2026-10-05 2026-10-05 0001638911 2026-01-01 2026-09-30 0001638911 srt:ChiefExecutiveOfficerMember us-gaap:ReportableSegmentAggregationBeforeOtherOperatingSegmentMember 2025-07-01 2025-09-30 0001638911 srt:ChiefExecutiveOfficerMember us-gaap:ReportableSegmentAggregationBeforeOtherOperatingSegmentMember 2026-07-01 2026-09-30 0001638911 srt:ChiefExecutiveOfficerMember us-gaap:ReportableSegmentAggregationBeforeOtherOperatingSegmentMember 2025-01-01 2025-09-30 0001638911 srt:ChiefExecutiveOfficerMember us-gaap:ReportableSegmentAggregationBeforeOtherOperatingSegmentMember 2026-01-01 2026-09-30 0001638911 us-gaap:ShareBasedCompensationAwardTrancheOneMember 2026-01-01 2026-09-30 0001638911 2026-09-30 0001638911 dukr:MrEranAntebiMember 2026-09-30 0001638911 dukr:MrEranAntebiMember 2026-01-01 2026-09-30 0001638911 dukr:MsKerenGousmanGolanMember 2026-09-30 0001638911 dukr:MsKerenGousmanGolanMember 2026-01-01 2026-09-30 0001638911 dukr:MrErezNachtomyMember 2026-09-30 0001638911 dukr:MrErezNachtomyMember 2026-01-01 2026-09-30 0001638911 dukr:MrVadimMaorMember 2026-09-30 0001638911 dukr:MrVadimMaorMember 2026-01-01 2026-09-30 0001638911 dukr:MrShlomoZakaiMember 2026-09-30 0001638911 dukr:MrShlomoZakaiMember 2026-01-01 2026-09-30 0001638911 dukr:MrYossefBaluckaMember 2026-09-30 0001638911 dukr:MrYossefBaluckaMember 2026-01-01 2026-09-30 0001638911 srt:MaximumMember 2026-03-10 0001638911 srt:MinimumMember 2026-03-10 0001638911 us-gaap:RelatedPartyMember 2026-03-10 0001638911 us-gaap:RelatedPartyMember 2026-01-01 2026-09-30 0001638911 us-gaap:RelatedPartyMember 2026-09-30 0001638911 dukr:BalancesWithRelatedPartiesMember us-gaap:RelatedPartyMember 2025-12-31 0001638911 dukr:BalancesWithRelatedPartiesMember us-gaap:RelatedPartyMember 2026-09-30 0001638911 dukr:TransactionsAndBalancesWithRelatedPartiesMember us-gaap:RelatedPartyMember 2025-07-01 2025-09-30 0001638911 dukr:TransactionsAndBalancesWithRelatedPartiesMember us-gaap:RelatedPartyMember 2026-07-01 2026-09-30 0001638911 dukr:TransactionsAndBalancesWithRelatedPartiesMember us-gaap:RelatedPartyMember 2025-01-01 2025-09-30 0001638911 dukr:TransactionsAndBalancesWithRelatedPartiesMember us-gaap:RelatedPartyMember 2026-01-01 2026-09-30 0001638911 2025-07-01 2025-09-30 0001638911 2025-01-01 2025-09-30 0001638911 dukr:ExercisePriceNinePointFourNineMember 2026-01-01 2026-09-30 0001638911 dukr:ExercisePriceNinePointFourNineMember 2026-09-30 0001638911 dukr:ExercisePriceSevenPointEightEightMember 2026-01-01 2026-09-30 0001638911 dukr:ExercisePriceSevenPointEightEightMember 2026-09-30 0001638911 dukr:ExercisePriceFiveSixPointTwoFiveMember 2026-09-30 0001638911 dukr:ExercisePriceFiveSixPointTwoFiveMember 2026-01-01 2026-09-30 0001638911 dukr:ExercisePriceTwoFivePointZeroZeroMember 2026-09-30 0001638911 dukr:ExercisePriceTwoFivePointZeroZeroMember 2026-01-01 2026-09-30 0001638911 dukr:ExercisePriceNinePointFiveZeroMember 2026-09-30 0001638911 dukr:ExercisePriceNinePointFiveZeroMember 2026-01-01 2026-09-30 0001638911 dukr:ExercisePriceFivePointTwoFiveMember 2026-09-30 0001638911 dukr:ExercisePriceFivePointTwoFiveMember 2026-01-01 2026-09-30 0001638911 2025-12-31 0001638911 dukr:YossefBaluckaMember 2026-07-01 0001638911 dukr:RepresentativeWarrantMember 2026-09-30 0001638911 dukr:UnderwritterMember 2026-01-01 2026-09-30 0001638911 us-gaap:OverAllotmentOptionMember 2026-05-18 2026-05-18 0001638911 us-gaap:CommonStockMember us-gaap:OverAllotmentOptionMember 2026-05-15 0001638911 us-gaap:CommonStockMember us-gaap:OverAllotmentOptionMember 2026-05-14 0001638911 us-gaap:CommonStockMember us-gaap:IPOMember 2026-05-14 0001638911 2026-05-14 2026-05-14 0001638911 us-gaap:IPOMember 2026-05-14 2026-05-14 0001638911 us-gaap:WarrantMember 2026-05-14 0001638911 2025-12-30 0001638911 2026-05-15 0001638911 us-gaap:MeasurementInputSharePriceMember 2025-12-30 0001638911 us-gaap:MeasurementInputSharePriceMember 2026-05-15 0001638911 dukr:ConversionPriceMember 2025-12-30 0001638911 dukr:ConversionPriceMember 2026-05-15 0001638911 srt:MaximumMember us-gaap:MeasurementInputExpectedTermMember 2025-12-30 0001638911 srt:MinimumMember us-gaap:MeasurementInputExpectedTermMember 2025-12-30 0001638911 us-gaap:MeasurementInputExpectedTermMember 2026-05-15 0001638911 us-gaap:MeasurementInputExpectedDividendRateMember 2025-12-30 0001638911 us-gaap:MeasurementInputExpectedDividendRateMember 2026-05-15 0001638911 srt:MaximumMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2025-12-30 0001638911 srt:MinimumMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2025-12-30 0001638911 us-gaap:MeasurementInputRiskFreeInterestRateMember 2026-05-15 0001638911 srt:MaximumMember us-gaap:MeasurementInputOptionVolatilityMember 2025-12-30 0001638911 srt:MinimumMember us-gaap:MeasurementInputOptionVolatilityMember 2025-12-30 0001638911 us-gaap:MeasurementInputOptionVolatilityMember 2026-05-15 0001638911 us-gaap:AdditionalPaidInCapitalMember 2026-01-01 2026-09-30 0001638911 us-gaap:CommonStockMember 2026-05-18 2026-05-18 0001638911 2026-01-01 2026-01-31 0001638911 2025-12-31 2025-12-31 0001638911 us-gaap:WarrantMember 2026-01-01 2026-09-30 0001638911 2026-05-18 2026-05-18 0001638911 dukr:TwoThousandTwentyFiveWarrantMember 2026-01-31 2026-01-31 0001638911 dukr:TwoThousandTwentyFiveWarrantMember 2025-01-01 2025-12-31 0001638911 us-gaap:IPOMember 2026-01-31 2026-01-31 0001638911 us-gaap:IPOMember 2025-01-01 2025-12-31 0001638911 us-gaap:IPOMember 2025-12-30 2025-12-30 0001638911 dukr:TwoThousandTwentyFiveWarrantMember 2026-05-18 2026-05-18 0001638911 us-gaap:WarrantMember 2025-12-30 0001638911 dukr:SecuritiesPurchaseAgreementMember us-gaap:WarrantMember 2025-12-30 0001638911 us-gaap:PrivatePlacementMember dukr:SecuritiesPurchaseAgreementMember 2025-12-30 0001638911 2026-03-10 0001638911 us-gaap:MeasurementInputSharePriceMember 2026-03-10 0001638911 us-gaap:MeasurementInputExercisePriceMember 2026-03-10 0001638911 srt:MinimumMember dukr:ContractualTermOfOptionsMember 2026-03-10 0001638911 srt:MaximumMember dukr:ContractualTermOfOptionsMember 2026-03-10 0001638911 us-gaap:MeasurementInputRiskFreeInterestRateMember 2026-03-10 0001638911 us-gaap:MeasurementInputOptionVolatilityMember 2026-03-10 0001638911 us-gaap:MeasurementInputExpectedDividendRateMember 2026-03-10 0001638911 2021-05-11 0001638911 us-gaap:WarrantMember 2021-05-11 0001638911 dukr:SecuritiesPurchaseAgreementMember us-gaap:WarrantMember 2021-05-11 0001638911 us-gaap:CommonStockMember 2021-05-11 0001638911 us-gaap:CommonStockMember 2021-05-11 2021-05-11 0001638911 2026-10-04 0001638911 2026-10-04 2026-10-04 0001638911 2022-04-22 0001638911 2022-04-04 2022-04-04 0001638911 dukr:ThirdYearLeasePaymentsMember 2022-04-04 2022-04-04 0001638911 dukr:FirstTwoYearsLeasePaymentsMember 2022-04-04 2022-04-04 0001638911 2022-04-04 0001638911 us-gaap:FairValueInputsLevel3Member 2025-12-31 0001638911 dukr:StockPurchaseWarrantsLiabilityMember 2025-12-31 0001638911 dukr:StockPurchaseWarrantsLiabilityMember us-gaap:FairValueInputsLevel3Member 2025-12-31 0001638911 us-gaap:CommonStockMember 2026-01-01 2026-09-30 0001638911 us-gaap:CommonStockMember 2026-02-15 2026-02-15 0001638911 us-gaap:CommonStockMember dukr:UnderwritingAgreementMember 2026-05-14 0001638911 us-gaap:CommonStockMember 2026-05-14 0001638911 dukr:UASAcquisitionCorpMember 2020-04-29 0001638911 2025-09-30 0001638911 2024-12-31 0001638911 us-gaap:RetainedEarningsMember 2025-09-30 0001638911 us-gaap:AccumulatedTranslationAdjustmentMember 2025-09-30 0001638911 us-gaap:AdditionalPaidInCapitalMember 2025-09-30 0001638911 us-gaap:CommonStockMember 2025-09-30 0001638911 us-gaap:RetainedEarningsMember 2025-07-01 2025-09-30 0001638911 us-gaap:AccumulatedTranslationAdjustmentMember 2025-07-01 2025-09-30 0001638911 us-gaap:AdditionalPaidInCapitalMember 2025-07-01 2025-09-30 0001638911 2025-06-30 0001638911 us-gaap:RetainedEarningsMember 2025-06-30 0001638911 us-gaap:AccumulatedTranslationAdjustmentMember 2025-06-30 0001638911 us-gaap:AdditionalPaidInCapitalMember 2025-06-30 0001638911 us-gaap:CommonStockMember 2025-06-30 0001638911 2025-04-01 2025-06-30 0001638911 us-gaap:RetainedEarningsMember 2025-04-01 2025-06-30 0001638911 us-gaap:AccumulatedTranslationAdjustmentMember 2025-04-01 2025-06-30 0001638911 us-gaap:AdditionalPaidInCapitalMember 2025-04-01 2025-06-30 0001638911 2025-03-31 0001638911 us-gaap:RetainedEarningsMember 2025-03-31 0001638911 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001638911 us-gaap:CommonStockMember 2025-03-31 0001638911 2025-01-01 2025-03-31 0001638911 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0001638911 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0001638911 us-gaap:RetainedEarningsMember 2024-12-31 0001638911 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001638911 us-gaap:CommonStockMember 2024-12-31 0001638911 us-gaap:RetainedEarningsMember 2026-09-30 0001638911 us-gaap:AccumulatedTranslationAdjustmentMember 2026-09-30 0001638911 us-gaap:AdditionalPaidInCapitalMember 2026-09-30 0001638911 us-gaap:CommonStockMember 2026-09-30 0001638911 us-gaap:RetainedEarningsMember 2026-07-01 2026-09-30 0001638911 us-gaap:AccumulatedTranslationAdjustmentMember 2026-07-01 2026-09-30 0001638911 us-gaap:CommonStockMember 2026-07-01 2026-09-30 0001638911 us-gaap:AdditionalPaidInCapitalMember 2026-07-01 2026-09-30 0001638911 2026-06-30 0001638911 us-gaap:RetainedEarningsMember 2026-06-30 0001638911 us-gaap:AdditionalPaidInCapitalMember 2026-06-30 0001638911 us-gaap:CommonStockMember 2026-06-30 0001638911 2026-04-01 2026-06-30 0001638911 us-gaap:RetainedEarningsMember 2026-04-01 2026-06-30 0001638911 us-gaap:AccumulatedTranslationAdjustmentMember 2026-04-01 2026-06-30 0001638911 us-gaap:AdditionalPaidInCapitalMember 2026-04-01 2026-06-30 0001638911 us-gaap:CommonStockMember 2026-04-01 2026-06-30 0001638911 2026-03-31 0001638911 us-gaap:RetainedEarningsMember 2026-03-31 0001638911 us-gaap:AccumulatedTranslationAdjustmentMember 2026-03-31 0001638911 us-gaap:AdditionalPaidInCapitalMember 2026-03-31 0001638911 us-gaap:CommonStockMember 2026-03-31 0001638911 2026-01-01 2026-03-31 0001638911 us-gaap:RetainedEarningsMember 2026-01-01 2026-03-31 0001638911 us-gaap:AccumulatedTranslationAdjustmentMember 2026-01-01 2026-03-31 0001638911 us-gaap:AdditionalPaidInCapitalMember 2026-01-01 2026-03-31 0001638911 us-gaap:CommonStockMember 2026-01-01 2026-03-31 0001638911 us-gaap:RetainedEarningsMember 2025-12-31 0001638911 us-gaap:AccumulatedTranslationAdjustmentMember 2025-12-31 0001638911 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0001638911 us-gaap:CommonStockMember 2025-12-31 0001638911 us-gaap:RelatedPartyMember 2025-12-31 0001638911 us-gaap:RelatedPartyMember 2026-09-30 0001638911 2026-11-16 0001638911 dukr:WarrantsEachToPurchaseOneShareOfCommonStockMember 2026-01-01 2026-09-30 0001638911 dukr:CommonStock00001ParValuePerShareMember 2026-01-01 2026-09-30 0001638911 us-gaap:AccumulatedTranslationAdjustmentMember 2024-12-31 0001638911 us-gaap:AccumulatedTranslationAdjustmentMember 2026-06-30 0001638911 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0001638911 us-gaap:AccumulatedTranslationAdjustmentMember 2025-01-01 2025-03-31 0001638911 us-gaap:CommonStockMember 2025-04-01 2025-06-30 0001638911 us-gaap:CommonStockMember 2025-07-01 2025-09-30 0001638911 us-gaap:AccumulatedTranslationAdjustmentMember 2025-03-31 0001638911 dukr:StockPurchaseWarrantsLiabilityMember us-gaap:FairValueInputsLevel1Member 2025-12-31 0001638911 dukr:StockPurchaseWarrantsLiabilityMember us-gaap:FairValueInputsLevel2Member 2025-12-31 0001638911 us-gaap:FairValueInputsLevel1Member 2025-12-31 0001638911 us-gaap:FairValueInputsLevel2Member 2025-12-31 iso4217:USD xbrli:shares xbrli:shares iso4217:USD dukr:Segments xbrli:pure iso4217:ILS

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q 

 

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 

 

For the quarterly period ended September 30, 2026 

 

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 

 

For the transition period from        to      

 

Commission File No. 001-43295 

  

DUKE Robotics Corp.
(Exact name of registrant as specified in its charter)

  

Nevada   47-3052410
(State or other jurisdiction of
incorporation or organization)
  (I.R.S. Employer
Identification No.)

 

10 HaRimon Street, Mevo Carmel Science and Industrial
Park, Israel
  2069203
(Address of Principal Executive Offices)   (Zip Code)

 

+972-054-5707050
(Registrant’s telephone number, including area code)

 

n/a
(Former name, former address and former fiscal year, if changed since last report)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class registered   Trading Symbol(s)   Name of exchange on which registered
Common stock, $0.0001 par value per share    DUKR   The Nasdaq Stock Market LLC
Warrants, each to purchase one share of common stock   DUKRW   The Nasdaq Stock Market LLC

  

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐ Accelerated filer ☐
Non-accelerated filer ☒ Smaller reporting company ☒
    Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒ 

 

As of November 16, 2026, the registrant had 3,425,978 shares of common stock, par value $0.0001, of the registrant issued and outstanding.

 

In this Quarterly Report, unless otherwise specified, all dollar amounts are expressed in United States dollars. Except as otherwise indicated by the context, references in this Quarterly Report to “Company”, “DUKE,” “we,” “us” and “our” are references to DUKE Robotics Corp. (formerly known as UAS Drone Corp.), a Nevada corporation, together with its consolidated subsidiaries.

 

 

 

 

DUKE Robotics Corp.

 

Quarterly Report on Form 10-Q

 

TABLE OF CONTENTS

 

  Page 
   
Cautionary Note Regarding Forward-Looking Statements ii
   
PART I - FINANCIAL INFORMATION  
     
Item 1. Consolidated Financial Statements (unaudited) 1
     
  Consolidated Balance Sheets 3
     
  Consolidated Statements of Comprehensive Loss 4
     
  Statements of Stockholders’ Equity 5
     
  Consolidated Statements of Cash Flows 6
     
  Notes to Consolidated Financial Statements 7
     
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 22
     
Item 3. Quantitative and Qualitative Disclosures about Market Risk 26
     
Item 4. Controls and Procedures 27
   
PART II - OTHER INFORMATION 28
   
Item 1A. Risk Factors 28
     
Item 5.  Other Information 28
     
Item 6. Exhibits 28
   
SIGNATURES 29

 

i

 

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS 

 

Certain information set forth in this Quarterly Report on Form 10-Q, including in Item 2, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and elsewhere herein may address or relate to future events and expectations and as such constitutes “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Statements that are not historical reflect our current expectations and projections about our future results, performance, liquidity, financial condition, prospects, and opportunities and are based upon information currently available to us and our management and their interpretation of what is believed to be significant factors affecting our business, including many assumptions regarding future events. Such forward-looking statements include statements regarding, among other things:

 

  ● sales of our products and the development of new potential products;

 

  ● the size and growth of our product market;

 

  ● our activity in the civilian market;

 

  ● our manufacturing capabilities;

 

  ● our entering into certain partnerships with third parties;

 

  ● obtaining required regulatory approvals for sales or exports of our products;

 

  ● our marketing plans;

 

  ● our expectations regarding our short- and long-term capital requirements;

 

  ● our outlook for the coming months and future periods, including but not limited to our expectations regarding future revenue and expenses; and

 

  ● information with respect to any other plans and strategies for our business.

 

Forward-looking statements, which involve assumptions and describe our future plans, strategies, and expectations, are generally identifiable by the use of the words “may,” “should,” “would,” “could,” “scheduled,” “expect,” “anticipate,” “estimate,” “believe,” “intend,” “seek,” or “project” or the negative of these words or other variations on these words or comparable terminology. Actual results, performance, liquidity, financial condition, and results of operations, prospects, and opportunities could differ materially and perhaps substantially from those expressed in, or implied by, these forward-looking statements as a result of various risks, uncertainties, and other factors. These statements may be found under the section of our Annual Report on Form 10-K for the year ended December 31, 2025 (filed on March 12, 2026) entitled “Risk Factors” as well as in our other public filings.

 

In light of these risks and uncertainties, and especially given the start-up nature of our business, there can be no assurance that the forward-looking statements contained herein will occur. Readers should not place undue reliance on any forward-looking statements. Except as expressly required by the federal securities laws, we undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, changed circumstances, or any other reason.

 

ii

 

Item 1. Financial Statements.

 

DUKE ROBOTICS CORP.

 

CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS (UNAUDITED)

 

AS OF SEPTEMBER 30, 2026

 

1

 

DUKE ROBOTICS CORP.

 

CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS (UNAUDITED)

 

AS OF SEPTEMBER 30, 2026

 

TABLE OF CONTENTS

 

    Page
CONDENSED CONSOLIDATED FINANCIAL STATEMENTS:    
Unaudited Condensed Consolidated Interim Balance sheets as of September 30, 2026, and December 31, 2025   3
Unaudited Condensed Consolidated Interim Statements of Comprehensive loss for nine and three months ended September 30, 2026 and 2025   4
Unaudited Condensed Consolidated Interim Statements of Stockholders’ Equity (deficit) for the period of nine and three months ended September 30, 2026 and 2025   5
Unaudited Condensed Consolidated Interim Statements of Cash Flows for the nine months ended September 30, 2026 and 2025   6
Notes to unaudited condensed consolidated financial statements   7 - 21

 

 

 

 

 

 

 

 

2

 

DUKE ROBOTICS CORP.

UNAUDITED CONDENSED CONSOLIDATED INTERIM BALANCE SHEETS

(USD in thousands, except share and per share data)

 

    September 30,     December 31,  
    2026     2025  
Assets            
Current Assets            
Cash and cash equivalents     6,409       750  
Restricted Cash     45       -  
Trade receivables     153       41  
Other current assets     119       116  
Total Current assets     6,726       907  
                 
Operating lease right-of-use asset and lease deposit     87       127  
                 
Property and equipment, net     166       215  
Total assets     6,979       1,249  
                 
Liabilities and Shareholders’ Equity                
Current Liabilities                
Accounts payable     238       129  
Operating lease liability     75       72  
Other liabilities     317       366  
Stock purchase warrants liability     -       189  
Total current liabilities     630       756  
                 
Related parties loans     336       330  
                 
Operating lease liability     14       63  
                 
Total liabilities     980       1,149  
                 
Stockholders’ Equity                
Common stock, US$ 0.0001 par value per share (“Common Stock”): 350,000,000 shares authorized as of September 30, 2026 and December 31, 2025; issued and outstanding 3,425,978 and 2,177,045 shares as of September 30, 2026 and December 31, 2025, respectively.     *       *  
Additional paid-in capital     24,801       12,505  
Foreign currency translation adjustments     2       (2 )
Accumulated deficit     (18,804 )     (12,403 )
Total stockholders’ Equity     5,999       100  
Total liabilities and stockholders’ Equity     6,979       1,249  

 

(*) represents amount less than $1 thousand.

 

The accompanying notes are an integral part of the condensed consolidated interim financial statements.

 

3

 

DUKE ROBOTICS CORP.

UNAUDITED CONDENSED CONSOLIDATED INTERIM STATEMENTS OF COMPREHENSIVE LOSS

(USD in thousands, except share and per share data)

 

    Nine months ended     Three months ended  
    September 30     September 30  
    2026     2025     2026     2025  
                         
Revenues     448       359       299       216  
Cost of revenues     (266 )     (156 )     (143 )     (93 )
Gross profit     182       203       156       123  
                                 
Research and development expenses     (159 )     (79 )     (98 )     (34 )
General and administrative expenses     (2,323 )     (875 )     (917 )     (302 )
Operating loss     (2,300 )     (751 )     (859 )     (213 )
Financing income (expenses), net     (160 )     (17 )     46       (17 )
Other loss     -       (10 )     -       -  
Net loss     (2,460 )     (778 )     (813 )     (230 )
Other comprehensive gain (loss) - Foreign currency translation adjustments     4       (1 )     2       1  
Comprehensive loss     (2,456 )     (779 )     (811 )     (229 )
                                 
Loss per share (basic and diluted) (*)     (0.86 )     (0.35 )     (0.24 )     (0.10 )
                                 
Basic and diluted weighted average number of shares of common stock outstanding (*)     2,844,349       2,195,045       3,425,978       2,195,045  

 

(*) Adjusted to reflect one (1) for twenty five (25) reverse stock split on March 6, 2026 (see note 1C)

 

The accompanying notes are an integral part of the condensed consolidated interim financial statements.

 

4

 

DUKE ROBOTICS CORP. 

UNAUDITED CONDENSED CONSOLIDATED INTERIM STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIT)

(USD in thousands, except share and per share data)

 

    Number of
Shares
    Amount     Additional
paid-in
capital
    Foreign
currency
translation
adjustments
    Accumulated
deficit
    Total
stockholders’
equity
 
                                     
BALANCE AT DECEMBER 31, 2025     **2,177,045       *       12,505       (2 )     (12,403 )     100  
Share based compensation for services     -       -       95       -       -       95  
Issuance of shares     83,338       *       152       -       -       152  
Warrants modification     -       -       3,941       -       (3,941 )     -  
Foreign currency translation adjustments     -       -       -       1       -       1  
Net loss for the period     -       -       -       -       (921 )     (921 )
BALANCE AT MARCH 31, 2026     2,260,383       *       16,693       (1 )     (17,265 )     (573 )
Share based compensation for services     -       -       168       -       -       168  
Issuance of shares and warrants, net of offering costs of $1,962 (note 4D)     1,125,000       *       7,263       -       -       7,263  
Issuance of shares pursuant to make-whole provision (note 4C)     22,595       *       -       -       -       -  
Reclassification of options from liability to equity upon elimination of make-whole provision (note 4C)     -       -       513       -       -       513  
Foreign currency translation adjustments     -       -       -       1       -       1  
Net loss for the period     -       -       -       -       (726 )     (726 )
BALANCE AT JUNE 30, 2026   3,407,978     *     24,637     *     (17,991 )   6,646  
Share based compensation for services     -       -       164       -       -       164  
Exercise of option     18,000       *       *       -       -       *  
Foreign currency translation adjustments     -       -       -       2       -       2  
Net loss for the period     -       -       -       -       (813 )     (813 )
BALANCE AT SEPTEMBER 30, 2026   3,425,978     *       24,801     2     (18,804 )   5,999  

   

    Number of
Shares
       Amount     Additional
paid-in
capital
    Foreign
currency
translation
adjustments
    Accumulated deficit     Total
stockholders’
equity
 
                                     
BALANCE AT DECEMBER 31, 2024     2,177,045       *       12,013       -       (11,162 )     851  
Share based compensation for services     -       -       10       -       -       10  
Foreign currency translation adjustments     -       -       -       (* )     -       (* )
Net loss for the period     -       -                       (279 )     (279 )
BALANCE AT MARCH 31, 2025     2,177,045       *       12,023       (* )     (11,441 )     582  
Share based compensation for services     -       -       67       -       -       67  
Foreign currency translation adjustments     -       -       -       (2 )     -       (2 )
Net loss for the period     -       -                       (269 )     (269 )
BALANCE AT JUNE 30, 2025     2,177,045       *       12,090       (2 )     (11,710 )     378  
Share based compensation for services     -       -       73       -       -       73  
Foreign currency translation adjustments     -       -       -       1       -       1  
Net loss for the period     -       -                       (230 )     (230 )
BALANCE AT SEPTEMBER 30, 2025     2,177,045       *       12,163       (1 )     (11,940 )     222  

  

(*) represents amount less than $1 thousand.
(**) See note 1C.

 

The accompanying notes are an integral part of the condensed consolidated interim financial statements.

 

5

 

DUKE ROBOTICS CORP.

UNAUDITED CONDENSED CONSOLIDATED INTERIM STATEMENTS OF CASH FLOWS

(USD in thousands, except share and per share data)

 

    Nine months ended  
    September 30,  
    2026     2025  
CASH FLOWS FROM OPERATING ACTIVITIES:            
Loss for the period     (2,460 )     (778 )
Adjustments required to reconcile net loss for the period to net cash used in operating activities:                
Depreciation     75       52  
Share based compensation     427       150  
Interest on loans from related parties     6       6  
Changes in fair value of warrant liability     214       -  
Reduction in the carrying amount of right-of-use assets     43       36  
Change in operating lease liabilities     (48 )     (20 )
Loss from sale of property and equipment     -       10  
Increase in trade receivable     (112 )     (199 )
Increase in other current assets     (3 )     (4 )
Increase in accounts payable     109       14  
Decrease in other liabilities     (39 )     (8 )
Net cash used in operating activities     (1,788 )     (741 )
                 
CASH FLOWS FROM INVESTING ACTIVITIES:                
Purchase of property and equipment     (26 )     (152 )
Net cash used in investing activities     (26 )     (152 )
                 
CASH FLOWS FROM FINANCING ACTIVITIES:                
Proceeds from share issuances, net of offering costs     7,524       -  
Net cash provided by financing activities     7,524       -  
                 
Effect of exchange rate changes on cash and cash equivalents     (6 )     2  
                 
INCREASE (DECREASE) IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH     5,704       (891 )
                 
CASH, CASH EQUIVALENTS AND RESTRICTED CASH AT BEGINNING OF PERIOD     750       1,287  
                 
CASH, CASH EQUIVALENTS AND RESTRICTED CASH AT END OF PERIOD     6,454       396  
Supplemental disclosure of cash flow information:            
Non cash transactions:            
Acquisition of vehicle via non-cash trade-in.     -       14  

 

The accompanying notes are an integral part of the condensed consolidated interim financial statements.

 

6

 

DUKE ROBOTICS CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

(USD in thousands, except share and per share data)

 

NOTE 1 – GENERAL

 

A. Duke Robotics Corp. (the “Company”) was incorporated under the laws of the State of Nevada on February 4, 2015.

 

On March 9, 2020, the Company closed on the Share Exchange Agreement (as defined hereunder), pursuant to which, Duke Robotics, Inc. (“Duke Inc.”) a corporation incorporated under the laws of the state of Delaware, became a majority-owned subsidiary of the Company. Duke Inc. has a wholly-owned subsidiary, Duke Airborne Systems Ltd. (“Duke Israel,” and collectively with Duke Inc., “Duke”), which was formed under the laws of the State of Israel in March 2014 and became the sole subsidiary of Duke after its incorporation.

 

On April 29, 2020, the Company, Duke Inc., and UAS Acquisition Corp., a Delaware corporation and a wholly-owned subsidiary of the Company (“UAS Sub”), executed an Agreement and Plan of Merger (the “Merger Agreement”), pursuant to which UAS Sub merged with and into Duke Inc., with Duke Inc. surviving as our wholly-owned subsidiary (the “Short-Form Merger”). Upon closing of the Short-Form Merger, each outstanding share of UAS Sub’s common stock, par value $0.0001 per share, was converted into and became one share of common stock of Duke Inc., with Duke Inc. surviving as a wholly-owned subsidiary of the Company.

 

Following the above transactions, Duke Israel became a wholly-owned subsidiary of Duke Inc., which is a wholly-owned subsidiary of the Company.

 

On February 18, 2025, the Company established Duke Robotics Hellas M I.K.E (“Duke Greece”), a wholly owned subsidiary, formed under the laws of Greece, to support the ongoing global commercialization efforts of the Company’s Insulator Cleaning (“IC”) Drone system.

 

The Company (collectively with Duke, the “Group”) is a robotics company dedicated to developing an advanced robotics stabilization system that enables remote, real-time, pinpoint accurate firing of small arms and light weapons as well as other civilian applications, with an emphasis in the field of routine infrastructure maintenance. The Company offers high-voltage insulator washing abilities using its innovative Insulator Cleaning (“IC”) Drone system. This technology provides an efficient and safe method for cleaning high-voltage insulators, improving their performance, enhancing safety, and reducing maintenance costs.

 

7

 

DUKE ROBOTICS CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

(USD in thousands, except share and per share data)

 

NOTE 1 – GENERAL (continued)

 

  B. On May 14, 2026, the Company entered into the underwriting agreement (the “Underwriting Agreement”) with Maxim Group LLC, as representative of the several underwriters (the “Underwriters”) relating to a public offering (the “Offering”) of 1,125,000 units, with each unit consisting of one share of Common Stock and warrants (the “Warrants”) to purchase one share of Common Stock at an exercise price of $8.60 per share, exercisable for a period of five years, subject to certain adjustments and cashless exercise provisions.

 

On May 18, 2026, the Company closed the Offering, as well as the partial exercise of the over-allotment option, and issued the Shares and Warrants, resulting in aggregate gross proceeds of approximately $9,225, before deducting underwriting discounts and commissions and other offering expenses of approximately $1,962. See note 4D below.

 

On May 14, 2026, the Company’s Common Stock and Warrants were approved for listing on the Nasdaq Capital Market, and on May 15, 2026, the Common Stock and Warrants began trading on the Nasdaq Capital Market under the symbols “DUKR” and “DUKRW,” respectively.

 

C. Reverse stock split

 

On August 12, 2025, the majority of the Company’s stockholders approved the Reverse Stock Split and on February 15, 2026, the Company’s Board of Directors approved a 1-for-25 reverse stock split (the “Reverse Stock Split”) of the Company’s issued and outstanding shares of Common Stock.

 

On March 4, 2026, the Company filed a Certificate of Amendment (the “Amendment”) to its Amended and Restated Certificate of Incorporation in Nevada to effect the Reverse Stock Split. The Amendment became effective on March 6, 2026.

 

As a result of the Reverse Stock Split, every 25 shares of the Company’s outstanding shares of Common Stock prior to the effect of the Amendment were combined and reclassified into one share of the Company’s Common Stock. No fractional shares were issued in connection with or following the reverse split and the shares were rounded to the nearest whole number. The authorized capital and par value of the Common Stock remained unchanged.

 

All shares, stock option and per share information in the 2025 consolidated financial statements have been restated to reflect the Reverse Stock Split on a retroactive basis.

 

8

 

DUKE ROBOTICS CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

(USD in thousands, except share and per share data)

 

NOTE 1 – GENERAL (continued)

 

D. Liquidity

 

Since inception, the Company has incurred losses and negative cash flows from operations. The Company has financed its operations mainly through fundraising from various investors.

 

As described in Note 1B above, on May 18, 2026, the Company closed the Offering resulting in aggregate gross proceeds of approximately $9,225 and commencing May 15, 2026, the Company’s Common Stock and Warrants began trading on the Nasdaq Capital Market. In light of the proceeds received from this fundraising, and based on the projected cash flows and cash balances as of the date of approval of these consolidated financial statements, management is of the opinion that the Company’s existing cash will be sufficient to meet its obligations for a period of more than 12 months from the date of approval of these consolidated financial statements.

 

E. In October 2023, a large-scale terrorist attack in southern Israel led to the outbreak of armed conflict between Israel and Hamas. The conflict subsequently expanded to additional regional fronts and contributed to a period of heightened geopolitical and security instability in the region.

 

During 2024 and 2025, hostilities included military operations in Lebanon and direct confrontations involving Iran. These developments increased regional uncertainty and, at times, resulted in temporary disruptions to the Company’s operations in Israel, including limited interruptions to routine business activities.

 

In September 2025, a ceasefire agreement was reached between Israel and Hamas, and all remaining living Israeli hostages were released and returned to Israel. While the ceasefire has generally held as of the date of these financial statements, the security situation remains sensitive, and the potential for renewed hostilities or broader regional escalation cannot be ruled out. More recently, on February 28, 2026, hostilities between Israel and Iran escalated again. Israel, together with the United States, conducted a major joint military campaign of air and missile strikes against targets in Iran, which triggered a broad Iranian response and contributed to significant regional instability. The situation remains highly fluid, and we are unable to predict when, or on what terms, this escalation will be resolved. Accordingly, the extent of the continued impact on the Company’s operations and financial results, if any, cannot be reasonably estimated at this time.

 

Given that the majority of the Company’s operations are conducted in Israel, and that all members of the Company’s board of directors and management, as well as most employees, consultants, and service providers, are located in Israel, the Company is directly affected by the economic, political, geopolitical, and military conditions impacting the region. As of September 30, 2026, while ceasefire arrangements with Hamas, Lebanon and Iran were generally in effect and large-scale military operations had subsided, the overall security environment in Israel and the surrounding region remained unstable and unpredictable. The recent hostilities resulted in temporary disruptions to the Company’s operations, resulting in a decrease in revenues during certain periods in 2025 and 2026, and may continue to have an adverse impact on certain business activities. Any further escalation or expansion of the conflict could negatively affect both regional and global conditions, and may adversely impact the Company’s business, financial condition, and results of operations.

 

9

 

DUKE ROBOTICS CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

(USD in thousands, except share and per share data)

 

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PRESENTATION

 

Basis of presentation

 

The accompanying unaudited condensed consolidated interim financial statements include the accounts of the Company and its subsidiaries, prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). In the opinion of management, the financial statements presented herein include all material adjustments (consisting of normal recurring adjustments) which are, in the opinion of the Company’s management, necessary for a fair statement of the financial condition, results of operations, changes in shareholders’ equity and cash flows for nine months ended September 30, 2026. However, these results are not necessarily indicative of results for any other interim period or for the year ended December 31, 2026. The preparation of financial statements in conformity with GAAP requires the Company to make certain estimates and assumptions for the reporting periods covered by the financial statements. These estimates and assumptions affect the reported amounts of assets, liabilities, revenues and expenses. Actual amounts could differ from these estimates

 

These financial statements should be read in conjunction with the audited financial statements included in the Company’s Form 10-K for the year ended December 31, 2025 as filed with the Securities and Exchange Commission. The Company’s significant accounting policies are disclosed in the audited financial statements for the year ended December 31, 2025 included in the Company’s Form 10-K. Since the date of such financial statements, there have been no changes to the Company’s significant accounting policies.

 

The accompanying unaudited condensed consolidated interim financial statements are prepared in accordance with GAAP. The unaudited condensed consolidated interim financial statements of the Company include the Company and its wholly-owned and majority-owned subsidiaries. All inter-company balances and transactions have been eliminated.

 

Use of Estimates

 

The preparation of unaudited condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, certain revenues and expenses, and disclosure of contingent assets and liabilities as of the date of the financial statements. Actual results could differ from those estimates.

 

10

 

DUKE ROBOTICS CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

(USD in thousands, except share and per share data)

 

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PRESENTATION (continued)

 

Fair Value Measurements

 

Fair value of certain of the Company’s financial instruments including cash, restricted cash, accounts receivable, account payable, accrued expenses, and other accrued liabilities approximate cost because of their short maturities. The Company measures and reports fair value in accordance with Accounting Standards Codification (“ASC”) 820, “Fair Value Measurements and Disclosure” (“ASC 820”) defines fair value, establishes a framework for measuring fair value in accordance with generally accepted accounting principles and expands disclosures about fair value investments.

 

Fair value, as defined in ASC 820, is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value of an asset should reflect its highest and best use by market participants, principal (or most advantageous) markets, and an in-use or an in-exchange valuation premise. The fair value of a liability should reflect the risk of non-performance, which includes, among other things, the Company’s credit risk.

 

Valuation techniques are generally classified into three categories: the market approach; the income approach; and the cost approach. The selection and application of one or more of the techniques may require significant judgment and are primarily dependent upon the characteristics of the asset or liability, and the quality and availability of inputs. Valuation techniques used to measure fair value under ASC 820 must maximize the use of observable inputs and minimize the use of unobservable inputs. ASC 820 also provides fair value hierarchy for inputs and resulting measurement as follows:

 

Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for identical assets or liabilities.

 

Level 2: Quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability; and inputs that are derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities; and

 

Level 3: Unobservable inputs for the asset or liability that are supported by little or no market activity, and that are significant to the fair values.

 

Fair value measurements are required to be disclosed by the Level within the fair value hierarchy in which the fair value measurements in their entirety fall. Fair value measurements using significant unobservable inputs (in Level 3 measurements) are subject to expanded disclosure requirements including a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings, and a description of where those gains or losses included in earning are reported in the statement of comprehensive loss.

 

11

 

DUKE ROBOTICS CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

(USD in thousands, except share and per share data)

 

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PRESENTATION (continued)

 

As of September 30, 2026, the Company had no financial liabilities measured at fair value on a recurring basis.

 

The Company’s financial liabilities that are measured at fair value on a recurring basis by level within the fair value hierarchy as of December 31, 2025 are as follows:

 

    As of December 31, 2025  
    Level 1     Level 2     Level 3     Total  
    US$  
                         
Stock purchase warrants liability     -       -       189       189  
Total     -       -       189       189  

  

NOTE 3 – LEASES

 

A. On April 4, 2022, the Company signed a lease agreement for an office space in Mevo Carmel Science and Industry Park, Israel for a term of 3 years, with an option to extend the term of the lease agreement for an additional 2 years. The monthly lease payments under the lease agreement for the first two years are NIS 16.5 (approximately $4.60) and for the third year NIS 17.2 (approximately $4.80). The monthly lease payments for the option period will be agreed between the parties, with a minimum increase of 5% above the third year monthly payment. Lease payments are linked to the Israeli Consumer Price Index. The property became available for Company’s use in February 2023. Based on the lease agreement terms, the Company made a deposit of $15 as a guarantee for its lease commitments. The Company utilized the two year extension option under the above lease agreement.

 

B. The components of operating lease expense for the period ended September 30, 2026 and 2025 were as follows:

 

   

Nine months ended

September 30,

 
    2026     2025  
                 
Operating lease expense     55       49  

 

12

 

DUKE ROBOTICS CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

(USD in thousands, except share and per share data)

 

NOTE 3 – LEASES (continued)

 

C. Supplemental cash flow information related to operating leases was as follows:

 

   

Nine months ended

September 30,

 
    2026     2025  
Cash paid for amounts included in the measurement of lease liabilities:            
Operating cash flows from operating leases     60       50  

 

D. Supplemental balance sheet information related to operating leases was as follows:

 

    September 30,     December 31,  
    2026     2025  
             
Operating leases:            
Operating leases right-of-use asset and lease deposit     87       127  
                 
Current operating lease liabilities     75       72  
Non-current operating lease liabilities     14       63  
Total operating lease liabilities     89       135  
                 
Weighted average remaining lease term (years)     1.34       2.08  
                 
Weighted average discount rate     8.75 %     8.75 %

 

E. Future minimum lease payments under non-cancellable leases as of September 30, 2026 were as follows:

 

2026     20  
2027     73  
2028     1  
Total operating lease payments     94  
Less: imputed interest     (5 )
Present value of lease liabilities     89  

 

13

 

DUKE ROBOTICS CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

(USD in thousands, except share and per share data)

 

NOTE 3 – LEASES (continued)

 

F. In September 2026, Duke Israel entered into an office space agreement with Fattal Workspace Limited Partnership for the use of office premises in Tel Aviv, Israel.

 

The agreement commenced on October 4, 2026, and has an initial term expiring on April 30, 2027. The monthly fee is NIS 36 thousand (approximately $12), subject to adjustments based on the Israeli Consumer Price Index. The agreement requires a refundable security deposit of NIS 64 thousand (approximately $21).

 

The agreement provides for automatic extensions of six months each, for up to four additional periods, unless either party provides written notice of non-renewal at least 45 days prior to the expiration of the applicable term. Management does not consider the extension periods to be reasonably certain and expects the agreement to expire at the end of its initial term. Accordingly, the Company expects to account for the arrangement under the short-term lease recognition exemption of ASC 842, recognizing lease expense over the lease term without recognizing a right-of-use asset or a corresponding lease liability.

 

NOTE 4 – SHAREHOLDERS’ EQUITY

 

Transactions:

 

A. Following the Reverse Stock Split effected on March 6, 2026, as detailed in note 1C above, the Company adjusted its number of outstanding shares of Common Stock as of December 31, 2025, to reflect the effect of additional 8,232 shares of Common Stock of the Company, issued to existing stockholders.

 

B. On May 11, 2021, the Company entered into securities purchase agreements with eight (8) non-U.S. investors, pursuant to which the Company, in a private placement offering, agreed to issue and sell to the investors an aggregate of: (i) 500,000 shares of Common Stock, at a price of $10.00 per share; and (ii) warrants to purchase 500,000 shares of Common Stock.

 

On May 11, 2021, the Company entered into a service agreement with a non-U.S. third party for financial and project oversight services in connection with an offering. Under the agreement, the Company agreed to pay the service provider 6% of the investment amounts received, and options to receive units, each consisting of one share and one warrant exercisable at $10.00 per share, equal to 6% of the investment amount received divided by $10.00. In the event that the offering investors exercise their warrants, the service provider is entitled to additional payments and options based on 6% of the investment and warrant exercise amounts received.

 

On March 10, 2026, the Company entered into warrant amendment agreements with the holders of the outstanding Warrants (the “2021 Warrants Amendment”). According to the 2021 Warrants Amendment, the Company and Holders agreed to extend the warrant exercise term of the Warrants from May 11, 2026 to May 1, 2031.

 

The Company accounted for the 2021 Warrant Amendments as deemed dividends. The fair value of the Warrant modifications was estimated using the Black-Scholes option-pricing model and is presented within the consolidated statements of changes in shareholders’ equity as a credit to additional paid in capital and a debit to the accumulated deficit.

 

The following are the data and assumptions used: 

 

    March 10,
2026
 
Dividend yield     0  
Expected volatility (%)     161.54 %
Risk-free interest rate (%)     3.73 %
Contractual term of options (years)     5.15-5.23  
Exercise price (US dollars)     16.25  
Share price (US dollars)     7  
Fair value (USD in thousands)     3,941  

 

14

 

DUKE ROBOTICS CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

(USD in thousands, except share and per share data)

 

NOTE 4 – SHAREHOLDERS’ EQUITY (continued)

 

  C. On December 30, 2025, the Company entered into securities purchase agreements (the “2025 Purchase Agreement”) with seven non-U.S. investors, pursuant to which the Company issued and sold in a private placement offering an aggregate of 83,338 shares of Common Stock and warrants to purchase 83,338 shares of Common Stock (“2025 Warrants”). The 2025 Warrants were exercisable immediately at an exercise price of $16.25 per share and were originally scheduled to expire on November 30, 2026. The 2025 Purchase Agreement also include a make-whole provision pursuant to which the investors may receive additional shares of Common Stock upon the occurrence of certain qualifying public offering events. As a result, on May 18, 2026, the Company issued 22,595 additional shares. The aggregate gross proceeds from the offering were approximately $750 of which $475 was received in December 2025 and $275 was received in January 2026 ($475 net in December 2025 and $261 net in January 2026).

 

The Company analyzed the 2025 Warrants, including the make-whole provision, in accordance with ASC 480, Distinguishing Liabilities from Equity, and ASC 815, Derivatives and Hedging, and concluded that the warrants do not meet the criteria for equity classification. The Company also concluded that the make-whole provision is not legally detachable and cannot be separately exercised and, therefore, is not a freestanding instrument. Accordingly, the warrants, inclusive of the make-whole provision, are accounted for as a single liability-classified instrument, initially recorded at fair value and remeasured at fair value at each reporting date, with changes in fair value recognized in the consolidated statements of operations until settlement or expiration.

 

On March 10, 2026, the Company entered into the Warrant Amendment Agreement with the investors of the 2025 Purchase Agreement, pursuant to which the term of the warrants was extended such that they expire on May 1, 2031. The Company accounted for the Warrant Amendment as deemed dividend. The fair value of the Warrant modifications was estimated using the Black-Scholes option-pricing model and is presented within the consolidated statements of changes in shareholders’ equity as a credit to additional paid in capital and a debit to the accumulated deficit.

 

On May 18, 2026, the Company completed the Offering as detailed in Note 1B. The Offering constituted a qualifying public offering event under the make-whole provision included in the 2025 Purchase Agreement. As a result, on May 18, 2026, the Company issued 22,595 additional shares of Common Stock in settlement of the make-whole provision. The initial fair value of the warrant liability attributable to the full amount of the offering was $299. As of December 31, 2025, only $189 of such amount was recognized, reflecting the portion attributable to the proceeds received through that date, with the remaining $110 recognized in January 2026 upon receipt of the remaining proceeds. Immediately prior to settlement, the Company remeasured the 2025 Warrants to a fair value of $513. The resulting change in fair value of $214 during the nine month ended September 30, 2026, was recognized within financing expenses, in the condensed consolidated interim statements of comprehensive loss.

 

15

 

DUKE ROBOTICS CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

(USD in thousands, except share and per share data)

 

NOTE 4 – SHAREHOLDERS’ EQUITY (continued)

 

Following settlement of the make-whole provision, the provision that had precluded equity classification was no longer applicable. The Company reassessed the classification of the remaining 2025 Warrants pursuant to ASC 480 and ASC 815 and concluded that the warrants met the criteria for equity classification. Accordingly, on May 15, 2026, the carrying amount of the remaining warrant liability of $513 was reclassified to additional paid-in capital. As of September 30, 2026, no liability remained in respect of the 2025 Warrants

 

Warrant liability

 

The fair value of warrants liability and the make-whole provision was calculated using a third-party specialist.

 

Prior to the occurrence of the qualifying public offering event, the calculations were based on the probability of the expected offering date, using the Black-Scholes option-pricing model and the make-whole provision was calculated using the Monte Carlo Simulation Model.

 

Following the completion of the public offering, the make-whole provision was measured through its settlement date based on the number of additional shares issuable pursuant to the provision and the applicable market price of the Common Stock. The fair value of the remaining 2025 Warrants immediately prior to their reclassification to equity was estimated using the Black-Scholes option-pricing model.

 

The assumptions used to perform the calculations are detailed below:

 

    May 15,
2026
    December 30,
2025
 
Expected volatility (%)     134.79 %     127.44% - 179.34 %
Risk-free interest rate (%)     4.26 %     3.47% - 3.48 %
Expected dividend yield     0.0 %     0.0 %
Expected term (years)     4.961       0.316-2.417  
Conversion price (U.S. dollars)     16.25       16.25  
Underlying share price (U.S. dollars)     7.46       6.25  
Fair value (U.S. dollars in thousands)     513       189  

 

D. Public Offering

 

On May 14, 2026, the Company entered into the Underwriting Agreement, relating to the Offering of 1,125,000 units, with each unit consisting of one share of Common Stock and warrants to purchase one share of Common Stock at an exercise price of $8.60 per share, exercisable for a period of five years, subject to certain adjustments and cashless exercise provisions. The combined public offering price per Unit was $8.20. Under the terms of the Underwriting Agreement, the Company granted the Underwriters an option, exercisable for 45 days following the closing of the Offering, to purchase up to an additional 168,750 shares of Common Stock and/or Warrants to purchase 168,750 shares of common stock to cover over-allotments, if any. On May 15, 2026, the Underwriter partially exercised its over-allotment option with respect to Warrants to purchase 168,750 shares of Common Stock.

 

16

 

DUKE ROBOTICS CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

(USD in thousands, except share and per share data)

 

NOTE 4 – SHAREHOLDERS’ EQUITY (continued)

 

On May 18, 2026, the Company closed the Offering, as well as the partial exercise of the over-allotment option, and issued the Shares and Warrants, resulting in aggregate gross proceeds of approximately $9,225, before deducting underwriting discounts and commissions and offering expenses.

 

Underwriting fees and other direct and incremental offering costs incurred in connection with the Offering amounted to approximately $1,962 and were recorded as a reduction of additional paid-in capital. Accordingly, the net proceeds from the Offering were approximately $7,263.

 

Concurrently with the closing of the Offering, the Company also issued warrants to the representatives (the “Representative’s Warrants”) to purchase an aggregate of up to 90,000 shares of its Common Stock to the Underwriters, with an exercise price of $ 5 per share. The Representative’s Warrants are exercisable beginning on November 14, 2026, and expire on November 14, 2031, pursuant to the terms and conditions of the Representative’s Warrants. The fair value of the Representative’s Warrants was accounted for as an offering cost and recorded as a reduction of additional paid-in capital.

 

The Company analyzed the Warrants and the Representative’s Warrants in accordance with ASC 480, Distinguishing Liabilities from Equity, and ASC 815-40, Derivatives and Hedging – Contracts in Entity’s Own Equity, and concluded that neither the Warrants nor the Representative’s Warrants meet the definition of a liability under ASC 480, that both instruments are indexed to the Company’s own Common Stock, and that both meet the conditions for equity classification set forth in ASC 815-40-25. Accordingly, the Warrants and the Representative’s Warrants were recorded as a component of additional paid-in capital upon issuance and are not subsequently remeasured.

 

As both the shares of Common Stock and the Warrants comprising each Unit are equity-classified financial instruments, no allocation of proceeds between the shares and the Warrants was required, and the gross proceeds from the Offering were recorded in the aggregate to Common Stock and additional paid-in capital.

 

  E. On July 1, 2026, Yossef Balucka, Company’s President and former Chief Executive Officer, exercised his existing option and purchased 18,000 shares of Common Stock at an exercise price of $0.0025 per share.

 

17

 

DUKE ROBOTICS CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

(USD in thousands, except share and per share data)

 

NOTE 5 – SHARE BASED COMPENSATION

 

The following table presents the Company’s stock option activity for the nine months ended September 30, 2026:

 

    Number of
Options
    Weighted
Average
Exercise Price
 
Outstanding at December 31, 2025     179,876       13.39  
Granted     156,300       8.07  
Exercised     (18,000 )     0.0025  
Forfeited or expired     -       -  
Outstanding at September 30, 2026     318,176       11.53  
Number of options exercisable at September 30, 2026     110,011       19.41  

 

The aggregate intrinsic value of the awards outstanding as of September 30, 2026 is $0. These amounts represent the total intrinsic value, based on the Company’s stock price of $5.20 as of September 30, 2026, less the weighted exercise price.

 

The stock options outstanding as of September 30, 2026, have been separated into exercise prices, as follows:

 

Exercise price     Stock
options
outstanding
    Weighted average
remaining contractual
life – years
    Stock
options
exercisable
 
      As of September 30, 2026  
  5.25       82,800       4.46       30,935  
  9.50       50,275       0.78       50,275  
  25.00       3,975       0.75       3,975  
  56.25       24,826       0.75       24,826  
  7.88       138,000       5.45       -  
  9.49     18,300     5.67     -  
          318,176       4.04       110,011  

  

Compensation expense recorded by the Company in respect of its share-based compensation awards for the nine months ended September 30, 2026 and 2025 were $427 and $150, respectively. Share-based compensation awards for the three months ended September 30, 2026 and 2025 were $164 and $73, respectively. These expenses are included in general and administrative expenses in the Statements of Operations.

 

18

 

DUKE ROBOTICS CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

(USD in thousands, except share and per share data)

 

NOTE 6 – RELATED PARTIES

 

A. Transactions and balances with related parties

  

   

Nine months ended

September 30

   

Three months ended

September 30,

 
    2026     2025     2026     2025  
                         
General and administrative expenses:                        
Directors and Officers compensation (*)     795       483       588       181  
                                 
(*) Share base compensation     185       111       137       52  
                                 
Financing:                                
Financing expense     6       6       2       2  

  

B. Balances with related parties:

 

    As of
September 30,
    As of December 31,  
    2026     2025  
             
Other accounts liabilities     65       117  
Loans (*)     336       330  

 

(*) The loans bear an annual fixed interest rate of 3% and shall be repaid (principal and interest) at the date upon which the Company raises at least $15 million and has achieved earnings before interest, tax, depreciation and amortization of $3 million.

 

19

 

DUKE ROBOTICS CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

(USD in thousands, except share and per share data)

 

NOTE 6 – RELATED PARTIES (continued)

 

  C. On March 10, 2026, the board of directors of the Company approved the issuance of options to purchase 138,000 shares of Common Stock to employees, directors and consultants pursuant to the Company’s 2021 Equity Incentive Plan (the “2021 Plan”) and in addition an increase in the number of shares of Common Stock available under the 2021 Plan from 360,000 to 480,000.

 

In addition, out of the options mentioned above, the board of directors approved the issuance of:

 

Name   Position   Number of
options
 
Mr. Yossef Balucka   Company’s President and former CEO     16,000  
Mr. Shlomo Zakai   Company’s former CFO     10,000  
Mr. Vadim Maor   Company’s CTO     4,000  
Mr. Erez Nachtomy   Active Vice Chairman of the board of the Company     16,000  
Ms. Keren Gousman Golan   Director of the Company     4,000  
Mr. Eran Antebi   Director of the Company     4,000  
          54,000  

 

All such options are exercisable at an exercise price of $7.88 per share, vest in three equal annual installments of 33% at the end of each year, expire six years from the date of grant, and are subject to the other terms and conditions set forth in the 2021 Plan.

 

NOTE 7 – SEGMENT INFORMATION

 

The Company has one operating and reportable segment, drone insulators washing activity.

 

The chief operating decision maker evaluates segment performance primarily based on segment operating loss.

 

20

 

DUKE ROBOTICS CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

(USD in thousands, except share and per share data)

 

NOTE 7 - SEGMENT INFORMATION (continued)

 

The Company refined the name of the segment previously referred to as “Revenue from drones insulators washing” to “Revenues from civil applications segment” to better reflect its nature. The change had no impact on the composition or nature of the segment’s activities.

 

The following table presents information about the Company’s reportable segment for the three and nine months ended September 30, 2026 and 2025:

 

Revenue related to the Company’s reportable segments is as follows:

 

    Nine months ended     Three months ended  
    September 30     September 30  
    2026     2025     2026     2025  
                         
Revenue from civil applications segment     448       343       299       216  
Cost of revenues from civil applications segment     (266 )     (156 )     (143 )     (93 )
Gross profit     182       187       156       123  
                                 
Other revenues     -       16       -       -  
                                 
Research and development expenses     (159 )     (79 )     (98 )     (34 )
Depreciation     (6 )     (13 )     (2 )     (4 )
Professional services     (1,500 )     (539 )     (552 )     (182 )
Share base compensation     (427 )     (150 )     (164 )     (73 )
Other general and administrative expenses     (390 )     (173 )     (199 )     (43 )
Operating loss     (2,300 )     (751 )     (859 )     (213 )
                                 
Interest expenses     (234 )     (101 )     (12 )     (30 )
Interest income     74       84       58       13  
Other expenses     -       (10 )     -       -  
Net loss     (2,460 )     (778 )     (813 )     (230 )

 

For the nine and three months ended September 30, 2026 and 2025, the Company’s operations were mostly confined to Israel. As of September 30, 2026 and 2025, all of the fixed assets of the Company were located in Israel and Greece.

 

NOTE 8 – SUBSEQUENT EVENTS

 

On October 5, 2026, the Company granted an aggregate of 144,600 stock options to certain officers and a director under its 2021 Plan, consisting of 53,600 options to the Chief Executive Officer, 35,000 options to the Chief Financial Officer, 28,000 options to the Chief Technology Officer and 28,000 options to the Vice Chairman.

 

The options have an exercise price of $5.45 per share and expire on October 5, 2032. The options vest over a three-year period, with one-third vesting on the first anniversary of the grant date and the remaining options vesting either quarterly over the following two years or annually on the second and third anniversaries of the grant date, depending on the applicable grant agreement. The options were granted pursuant to the Company’s existing 2021 Plan and are subject to the terms and conditions of the applicable award agreements.

 

21

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

Readers are advised to review the following discussion and analysis of our financial condition and results of operations together with our consolidated financial statements and related notes thereto included elsewhere in this Quarterly Report on Form 10-Q and the consolidated financial statements and related notes thereto in our Annual Report on Form 10-K for the year ended December 31, 2025. Some of the information contained in this discussion and analysis or set forth elsewhere in this Quarterly Report, including information with respect to our plans and strategy for our business, includes forward-looking statements that involve risks and uncertainties. See “Cautionary Note Regarding Forward-Looking Statements”. You should review the “Risk Factors” section of our Annual Report for the fiscal year ended December 31, 2025 for a discussion of important factors that could cause actual results to differ materially from the results described in or implied by the forward-looking statements contained in the following discussion and analysis.

 

We are a robotics company developing advanced robotic and drone-based systems. Our technologies include an advanced robotic stabilization system that enables remote, real-time, pinpoint-accurate firing of small arms and light weapons, as well as civilian drone-based solutions focused on infrastructure maintenance, which is a drone technology for conducting routine maintenance of critical infrastructure for electric utility insulator cleaning.

 

Although our stabilization technology was initially designed for use on unmanned aerial systems (“UAS”), our robotic solutions are adaptable to other military platforms and civilian applications.

 

On January 29, 2021, we, through Duke Airborne Systems Ltd. (“Duke Israel”), and Elbit Systems Land Ltd., an Israeli corporation (“Elbit”), entered into a collaboration agreement (the “Collaboration Agreement”) for the global marketing and sales, and the production and further development by Elbit of our developed advanced robotic system mounted on a UAS armed with lightweight firearms, which we then marketed under the commercial name “TIKAD.” On April 2, 2025, we and Elbit executed a supplement letter (the “Supplement Letter”) to the Collaboration Agreement relating to the stabilized weapons drone system technology that Elbit has been marketing and deploying under the brand name “Bird of Prey”. Pursuant to the Supplement Letter, we and Elbit have agreed to expand our collaboration to allow us to market the system to military, defense, home-land security and para-military customers, in coordination with Elbit. We will be entitled to a commission fee, in the mid-single figure percentage range, from any proceeds resulting from our marketing activities, in addition to the royalties we will receive as part of the Collaboration Agreement.

 

On August 15, 2022, Duke Israel introduced the Insulator Cleaning (“IC”) Drone, a drone technology for conducting routine maintenance of critical infrastructure, and has signed an agreement with Israel Electric Corporation Ltd. (the “IEC”) to provide drone-enabled systems for cleaning electric utility cable insulators. During October 2023, we completed our obligations under the agreement with the IEC. This was followed in August 2024, by a new agreement with the IEC to utilize our innovative IC Drone system for cleaning electric utility cable insulators. On May 12, 2025, we announced the successful commencement of our 2025 insulator cleaning activity in Israel with the IEC under our previously announced service agreement. On June 10, 2025, we announced the launch of our next-generation IC Drone System - the ICDS2 - representing a significant technological advancement in our innovative utility maintenance drone solution. The ICDS2 features several key technological advancements over its predecessor, featuring extended flight time, higher payload capacity, enhanced stability, advanced radar and improved cleaning durability. It was successfully deployed at the start of the insulator cleaning season in May 2025, marking a full-season operational timeline compared to 2024’s mid-season commencement. On June 2, 2026, we announced the successful commencement of our 2026 IC Drone season with the IEC, under the expanded service agreement. The 2026 cleaning season was executed with a materially broader operational footprint than any prior season, encompassing a substantially larger volume of high-voltage insulators serviced and an increased number of active field crews deploying our ICDS2. During the third quarter of 2026, we continued servicing high-voltage insulators for the IEC under the expanded March 2026 purchase order. Due to certain operational constraints experienced during the 2026 cleaning season, we now expect part of the work under the expanded purchase order to continue into the 2027 cleaning season. Notwithstanding this, we expect the expanded purchase order to be completed in full.

 

In February 2026, we announced the introduction of AEROTRACE™, an aerial monitoring and intelligence solution integrating a combination of capabilities and developments in the fields of hardware, sensors, software and artificial intelligence (“AI”), including through collaboration with other parties, designed to support infrastructure operators in assessing asset conditions and enhancing situational awareness. AEROTRACE™ integrates aerial data capture with software-driven analytics, including AI-assisted image analysis, to help identify areas of interest and potential anomalies across large-scale and distributed infrastructure assets. AEROTRACE™ is designed to be deployed as a standalone monitoring solution and may also complement our existing robotic IC Drone services by informing maintenance planning and prioritization. The introduction of AEROTRACE™ reflects our ongoing efforts to expand our technology portfolio beyond robotic hardware to include data- and intelligence-driven solutions.

 

On November 4, 2026, we entered into a strategic collaboration agreement (the “CRONOS Agreement”) with Cronos Security EPE and Cronos Security Services AE (collectively, “CRONOS”), Greek security and technology services companies, to jointly pursue commercial opportunities in Greece and bring our Insulator Cleaning Drone (“IC Drone”) technology to the Greek market on an exclusive basis. Under the CRONOS Agreement, we and CRONOS will work together to identify, develop and pursue commercial opportunities across Greece, including jointly participating in public and private tenders and providing marketing, operational and technical support for grid-maintenance services. The parties have already identified potential large-scale projects in Greece that we believe are well suited to our IC Drone technology and have significant near-term revenue potential. The CRONOS Agreement has an initial term of three years and provides that the parties will share in the profits of projects undertaken jointly, with us receiving the majority share. The collaboration builds on Duke Greece’s receipt of operational authorization from the Hellenic Civil Aviation Authority earlier in 2026 and supports our international expansion efforts. There can be no assurance that any identified opportunities will result in binding customer contracts or generate revenues.

 

22

 

On May 14, 2026, we entered into an underwriting agreement (the “Underwriting Agreement”) with Maxim Group LLC, as representative of the several underwriters identified therein (the “Underwriters”), relating to the public offering (the “Offering”) of 1,125,000 units, with each unit consisting of one share of our common stock, par value $0.0001 (the “Shares”), and warrants to purchase one share of our common stock (the “Warrants”) at an exercise price of $8.60 per share, exercisable for a period of five years, subject to certain adjustments and cashless exercise provisions. The combined public offering price per unit was $8.20. Under the terms of the Underwriting Agreement, we granted the Underwriters an option, exercisable for 45 days following the closing of the Offering, to purchase up to an additional 168,750 shares of common stock and/or Warrants to purchase 168,750 shares of common stock to cover over-allotments, if any. On May 15, 2026, the Underwriter partially exercised its over-allotment option with respect to Warrants to purchase 168,750 shares of common stock. On May 18, 2026, we closed the Offering, as well as the partial exercise of the over-allotment option, and issued the Shares and Warrants, resulting in aggregate gross proceeds of approximately $9,225,000, before deducting underwriting discounts and commissions and estimated offering expenses.

 

On May 14, 2026, our common stock and Warrants were approved for listing on the Nasdaq Capital Market, and on May 15, 2026, our common stock and Warrants began trading on the Nasdaq Capital Market under the symbols “DUKR” and “DUKRW,” respectively.

 

On June 7, 2026, our Board of Directors (the “Board”) approved the appointment of Mr. Yiftach Kleinman as our Chief Executive Officer, effective upon the commencement of his employment with the Company, which occurred on September 8, 2026. Upon effectiveness, the Board relieved Mr. Yossi Balucka from his role as Chief Executive Officer of the Company. Mr. Balucka continues to serve as the Company’s President.

 

On September 15, 2026, our Board approved the appointment of Mr. Avi Levin as our Chief Financial Officer, effective October 1, 2026. Upon effectiveness, the Board relieved Mr. Shlomo Zakai from his role as Chief Financial Officer of the Company.

  

Critical Accounting Policies

 

In connection with the preparation of our financial statements, we were required to make assumptions and estimates about future events and apply judgments that affect the reported amounts of assets, liabilities, revenue, expenses, and related disclosures. We base our assumptions, estimates, and judgments on historical experience, current trends, and other factors that management believes to be relevant at the time our consolidated financial statements are prepared. Regularly, management reviews the accounting policies, assumptions, estimates, and judgments to ensure that our financial statements are presented fairly and in accordance with accounting principles generally accepted in the United States of America. However, because future events and their effects cannot be determined with certainty, actual results could differ from our assumptions and estimates, and such differences could be material.

 

Please see Note 2 of Part I, Item 1, of this Quarterly Report on Form 10-Q for the summary of significant accounting policies. In addition, reference is made to Part I, Item 7. “Management’s Discussion and Analysis of Financial Condition and Results of Operation” of our Annual Report on Form 10-K for the year ended December 31, 2025 (filed on March 12, 2026) concerning our Critical Accounting Policies and Estimates.

 

Results of Operations

 

Comparison of the three months ended September 30, 2026 and 2025

 

Revenues. Revenues for the three months ended September 30, 2026, amounted to $299,000, compared to $216,000 in revenues during the three months ended September 30, 2025. The increase in revenues is attributable to an increase in revenues from our IC Drone insulator cleaning activities.

 

Cost of revenues. Our cost of revenues for the three months ended September 30, 2026, amounted to $143,000, compared to $93,000 in cost of revenues for the three months ended September 30, 2025. The cost of revenues mainly consists of operational costs associated with our agreements with the IEC as detailed above. The increase in cost of revenues was primarily attributed to an increase in depreciation and operational costs associated with our IC Drone insulator cleaning activities.

 

23

 

Research and Development. Our research and development expenses for the three months ended September 30, 2026, amounted to $98,000 compared to $34,000 for the three months ended September 30, 2025. The increase in research and development expenses was mainly due to continued improvements to our insulator washing system.

 

General and Administrative. Our general and administrative expenses for the three months ended September 30, 2026, which consisted primarily of professional services, such as accounting, auditing, stock-based compensation expenses, insurance costs, consulting and legal services, amounted to $917,000, compared to $302,000 for the three months ended September 30, 2025. The increase in general and administrative expenses for the three months ended September 30, 2026 was mainly due to increase in professional services, such as strategic consulting and advisory board compensation expenses and stock-based compensation expenses, attributable to equity awards granted in March 2026.

 

Financial Income (expenses), net. For the three months ended September 30, 2026, we had financial income of $46,000 compared to financial expenses of $17,000 for the three months ended September 30, 2025. The increase in financial income for the three months ended September 30, 2026, was mainly attributable to interest income earned on bank deposits, reflecting higher cash balances following the Company’s equity financings during 2026.

 

Net Loss. We incurred a net loss of $813,000 for the three months ended September 30, 2026, as compared to a net loss of $230,000 for the three months ended September 30, 2025, for the reasons set forth above. 

 

Comparison of the nine months ended September 30, 2026 and 2025

 

Revenues. Revenues for the nine months ended September 30, 2026 amounted to $448,000, compared to $359,000 in revenues during the nine months ended September 30, 2025. The increase in revenues is attributable to an increase in revenues from our IC Drone insulator cleaning activities.

 

Cost of revenues. Our cost of revenues for the nine months ended September 30, 2026, amounted to $266,000, compared to $156,000 for the nine months ended September 30, 2025. The cost of revenues mainly consists of operational costs associated with our agreements with the IEC as detailed above. The increase in cost of revenues was primarily attributable to an increase in depreciation and operational costs associated with our IC Drone insulator cleaning activities.

 

Research and Development. Our research and development expenses for the nine months ended September 30, 2026, amounted to $159,000 compared to $79,000 for the nine months ended September 30, 2025. The increase in research and development expenses was mainly due to continued improvements to our insulator washing system.

 

General and Administrative. Our general and administrative expenses for the nine months ended September 30, 2026, which consisted primarily of professional services, such as accounting, auditing, stock-based compensation expenses, insurance costs, consulting and legal services, amounted to $2,323,000, compared to $875,000 for the nine months ended September 30, 2025. The increase in general and administrative expenses for the nine months ended September 30, 2026 was mainly due to approximately $445,000 in professional services attributable to one-time expenses related to our Nasdaq uplisting and the associated Offering described above, as well as an increase in other professional services, such as strategic consulting and advisory board compensation expenses and stock-based compensation expenses, attributable to equity awards granted in March 2026.

 

Financing expenses, net, were $160,000 for the nine months ended September 30, 2026, compared to financing expenses, net, of $17,000 for the same period in 2025, primarily reflecting non-cash mark-to-market changes in the warrant liability issued in the Company’s December 2025 private placement. Following the March 2026 amendment extending the term of those warrants to May 2031, the warrant liability was remeasured upward during the first quarter of 2026, resulting in a mark-to-market loss. Upon completion of the Company’s May 2026 underwritten public offering, the warrants were remeasured a final time and reclassified from liability to equity, resulting in a mark-to-market gain in the second quarter that partially offset the first-quarter loss, together with interest income earned on bank deposits.

 

Net Loss. We incurred a net loss of $2,460,000 for the nine months ended September 30, 2026, as compared to a net loss of $778,000 for the nine months ended September 30, 2025, for the reasons set forth above.

 

24

 

Liquidity and Capital Resources

 

As of September 30, 2026, we had $6,409,000 in cash and cash equivalents, compared to $361,000 in cash and cash equivalents on September 30, 2025. The reason for the increase in our cash balance was primarily attributable to net proceeds received from our May 2026 public offering of $7,263,000, as well as proceeds from the issuance of shares under our December 30, 2025 private placement partially offset by cash used in operating activities, including expenses described above. Cash used in operations for the nine months ended September 30, 2026 was $1,788,000 as compared to cash used in operations of $741,000 for the nine months ended September 30, 2025. The increase in cash used in operations was primarily attributable to one-time expenses related to our Nasdaq uplisting and the associated offering and an increase in our operating expenses described above.

 

Net cash used in investing activities was $26,000 for the nine months ended September 30, 2026, as compared to net cash used in investing activities of $152,000 for the nine months ended September 30, 2025.

 

Net cash provided by financing activities was $7,524,000 for the nine months ended September 30, 2026, compared to net cash used in financing activities of $0 for the nine months ended September 30, 2025. The increase was primarily attributable to proceeds received from our May 18, 2026 public offering of $7,263,000 as well as proceeds from issuance of shares under our December 30, 2025 private placement.

 

Since our inception we and Duke have funded our operations through equity and debt financing, bank loans, loans provided by shareholders, demonstration projects of its technology to potential customers and providing our ICD services to the IEC.

  

Since Duke’s inception and until 2017, certain Duke affiliates provided loans to Duke from time to time, as needed. Before entering into the Share Exchange, Duke entered into debt cancellation letters (the “Debt Cancellation Letters”) with regard to the Stockholders Loans. Pursuant to the Debt Cancellation Letters the accumulated interest on the Stockholders’ Loans was waived and 842,135 shares of Duke’s common stock were issued in exchange for the cancellation of $623,180 in debt, leaving $280,000 of outstanding Stockholders Loans (the “Outstanding Stockholders’ Loans”). The Outstanding Stockholders’ Loans, including the accumulated interest amount, shall be repaid on the later of the following: (i) three years after the Effective Date (March 9, 2020); or (ii) Duke raised capital amounting to at least $15 million following the Effective Date and the Earnings before interest, tax, depreciation and amortization of Duke has reached an amount of $3 million.

 

As of September 30, 2026 and September 30, 2025, the outstanding balances of such stockholders’ loans were $336,000 and $328,000, respectively.

 

On May 11, 2021, we entered into securities purchase agreements with eight (8) non-U.S. investors, pursuant to which we, in a private placement offering, agreed to issue and sell to investors an aggregate of: (i) 500,000 shares of our Common Stock at a price of $10.00 per share; and (ii) warrants to purchase 500,000 of our Common Stock. The warrants were exercisable immediately and for a term of 18 months and have an exercise price of $10 per share. The aggregate gross proceeds from the offering were approximately $5,000,000 and the offering closed on May 11, 2021. On April 5, 2022, we entered into an agreement with the Investors pursuant to which we extended the term of the warrants, to expire on November 11, 2023. On November 1, 2023, we and the Investors executed a second extension agreement, such that the term of the warrants was extended to expire on November 11, 2024. On June 20, 2024, we entered into a Warrant Amendment Agreement with the Investors to amend the terms of the warrants issued in connection with the May 11, 2021 securities purchase agreements. Under the Warrant Amendment Agreement, we and the Investors agreed to: (i) extend the warrant exercise term to May 11, 2026; (ii) amend the warrant exercise price, increasing it from $10.00 per share to $16.25 per share; and (iii) include a beneficial ownership blocker that limits the exercise of such warrants if the exercise would result in the holder beneficially owning more than 19.99% of the Company’s common stock immediately following the exercise. On March 10, 2026, we entered into an additional Warrant Amendment Agreement with the Investors pursuant to which we extended the term of the warrants to expire on May 1, 2031.

 

25

 

On December 30, 2025, we entered into securities purchase agreements with seven (7) non-U.S. investors, pursuant to which we, in a private placement offering, agreed to issue and sell to the investors an aggregate of: (i) 83,338 shares of our common stock at a price of $9.00 per share; and (ii) warrants to purchase 83,338 shares of common stock. The warrants have an exercise price of $16.25 per share, are exercisable immediately and expire on November 30, 2026. In addition, the securities purchase agreement contains a make whole provision that provides for the investors to receive additional shares of Common Stock in the event that we consummate a firm-commitment underwritten public offering on a major stock exchange by November 30, 2026 at a price per share (after giving effect to a 20% discount) that is less than the Purchase Price. On May 18, 2026, we consummated an underwritten public offering at a combined public offering price of $8.20 per unit, which triggered the make-whole provision. Accordingly, we issued an aggregate of 22,595 additional shares of Common Stock to the investors in settlement of the make-whole provision. The aggregate gross proceeds from the offering were approximately $750,000 and the offering closed on January 6, 2026. Proceeds from the December 2025 private placement offering were used for general corporate purposes and working capital, including supporting our operational and commercialization initiatives. On March 10, 2026, we entered into an additional Warrant Amendment Agreement with the Investors pursuant to which we extended the term of the warrants to expire on May 1, 2031.

 

On May 14, 2026, we entered into the Underwriting Agreement with the Underwriters relating to the Offering of 1,125,000 units, with each unit consisting of one share of our common stock and warrants to purchase one share of our common stock at an exercise price of $8.60 per share, exercisable for a period of five years, subject to certain adjustments and cashless exercise provisions. The combined public offering price per unit was $8.20. Under the terms of the Underwriting Agreement, we granted the Underwriters an option, exercisable for 45 days following the closing of the Offering, to purchase up to an additional 168,750 shares of common stock and/or Warrants to purchase 168,750 shares of common stock to cover over-allotments, if any. On May 15, 2026, the Underwriter partially exercised its over-allotment option with respect to Warrants to purchase 168,750 shares of common stock.

  

On May 18, 2026, we closed the Offering, as well as the partial exercise of the over-allotment option, and issued the Shares and Warrants, resulting in aggregate gross proceeds of approximately $9,225,000, before deducting underwriting discounts and commissions and estimated offering expenses. Concurrently with the closing of the Offering, we also issued warrants to purchase an aggregate of up to 90,000 shares of common stock to the representative of the Underwriters, with an exercise price of $10.25 per share (the “Representative’s Warrants”). The Representative’s Warrants are exercisable beginning on November 14, 2026, and expire on November 14, 2031, pursuant to the terms and conditions of the Representative’s Warrants.

 

As a result of the Offering, we issued 22,595 shares of common stock as a result of the make whole provision contained in the warrants issued to investors in our December 2025 private placement.

 

We have an effective Form S-3 registration statement (File No. 333-298400), filed under the Securities Act of 1933, as amended, with the SEC using a “shelf” registration process. Under this shelf registration process, we may, from time to time, sell our stock and warrants to purchase common stock, and of two or more such securities, in one or more offerings for an aggregate initial offering price of $50 million.

 

We currently believe that our existing capital resources will be sufficient to fund our operations for at least twelve months from the date of this Quarterly Report. 

 

Off-Balance Sheet Arrangements

 

As of September 30, 2026, we did not have any off-balance sheet arrangements as defined in Item 303(a)(4) of Regulation S-K.

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

 

We are a smaller reporting company and therefore are not required to provide the information for this item of Form 10-Q.

 

26

 

Item 4. Controls and Procedures.

 

Evaluation of Disclosure Controls and Procedures

 

As of the end of the period covered by this Report, our Chief Executive Officer and Chief Financial Officer (“the Certifying Officers”), conducted evaluations of our disclosure controls and procedures. As defined under Sections 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended, or the Exchange Act, the term “disclosure controls and procedures” means controls and other procedures of an issuer that are designed to ensure that information required to be disclosed by the issuer in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the Securities and Exchange Commission. Disclosure controls and procedures include without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Exchange Act is accumulated and communicated to the issuer’s management, including the Certifying Officers, to allow timely decisions regarding required disclosures.

 

Based on their evaluation, the Certifying Officers concluded that, as of September 30, 2026, our disclosure controls and procedures were effective.

 

Changes in Internal Control over Financial Reporting

 

There were no changes in our internal control over financial reporting that occurred during the quarter ended September 30, 2026, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

27

 

PART II - OTHER INFORMATION

 

Item 1A. Risk Factors

 

In addition to the other information set forth in this Quarterly Report on Form 10-Q, you should carefully consider the factors discussed in Part I, “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2025, which could materially affect our business, financial condition, or future results.

 

There have been no material changes from the risk factors previously disclosed in our Annual Report on Form 10-K for the year ended December 31, 2025.

 

Item 5. Other Information

 

On November 15, 2026, we entered into a Third Amendment to Services Agreement (the “Third Amendment”) with Mr. Yossef Balucka, amending his existing Services Agreement, dated March 25, 2021, as previously amended on August 4, 2024 and August 12, 2026 (as amended, the “Services Agreement”).

 

Pursuant to the Third Amendment, effective November 1, 2026, the scope of services to be provided by Mr. Balucka will be reduced for the period commencing November 1, 2026 and ending April 30, 2027 (the “Reduced Services Period”), during which Mr. Balucka will remain available to provide services to the Company as needed and in coordination with him. During the Reduced Services Period, Mr. Balucka will receive a monthly consulting fee of NIS 20,000, plus applicable value-added tax.

 

The Third Amendment further provides that any continuation of the services following the Reduced Services Period, or extension thereof, will be subject to the parties’ prior mutual written agreement. In the absence of such agreement, the Services Agreement will terminate on April 30, 2027.

 

Except as expressly amended by the Third Amendment, the terms of the Services Agreement remain unchanged.

 

The foregoing description of the Third Amendment is qualified in its entirety by reference to the full text of the Third Amendment, a copy of which is filed as Exhibit 10.2 to this Quarterly Report on Form 10-Q and incorporated herein by reference.

 

During the quarter ended September 30, 2026, none of our directors or officers adopted or terminated any “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.

 

Item 6. Exhibits.

 

No.   Description of Exhibit
10.1   Personal Employment Agreement, dated September 15, 2026, by and between Duke Robotics Corp. and Avi Levin (incorporated by reference to Exhibit 10.1 to the registrant’s Current Report on Form 8-K filed with the Securities and Exchange Commission on September 17, 2026).
10.2*   Third Amendment to Services Agreement, effective November 1, 2026, by and between Duke Robotics Corp. and Yossef Balucka.
31.1*   Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a).
31.2*   Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a).
32.1**   Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350.
32.2**   Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350.
101. INS   Inline XBRL Instance Document.
101. SCH   Inline XBRL Taxonomy Extension Schema Document.
101. CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101. DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document.
101. LAB   Inline XBRL Taxonomy Extension Label Linkbase Document.
101. PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document.
104   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

 

* Filed herewith.

** Furnished herewith

 

28

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: November 16, 2026 DUKE Robotics Corp.
   
  By: /s/ Yiftach Kleinman
    Name:  Yiftach Kleinman
    Title: Chief Executive Officer
      (Principal Executive Officer)
       
  By: /s/ Avi Levin
    Name: Avi Levin
    Title: Chief Financial Officer
(Principal Financial Officer)

  

29

Keep reading